AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
GEFITINIB in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GEFITINIB TABLET, COATED; ORAL | 2022/9.4/6260 | CIPLA LTD | active | 31 Dec 2027 |
GEFITINIB — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing GEFITINIB, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track GEFITINIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.